Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AMPH Amphastar Pharmaceuticals Inc

45,21

0,99 (2,24%)

27 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Amphastar Pharmaceuticals Charts.

News Amphastar Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 7 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 5 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 30 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Amphastar Pharmaceuticals Inc News-Artikel

SER EDUCACIONAL

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen